Cell Therapies and Regenerative Medicine

The Cell Therapy and Regenerative Medicine Platform hosts a biological Isolator that provides a fully contained environment suitable for the processing of human cells and tissue. This facility has been established to boost the clinical development of human cell-based therapies and regenerative medicine applications.

The Platform provides a flexible, cost-effective alternative to traditional cell therapy manufacturing and regenerative medicine facilities. It is available to researchers and commercial entities from within and outside the MHTP seeking to progress cell and tissue based therapies to the clinic. The platform houses the BioSpherix Xvivo ISO5 Isolator, an enclosed, integrated and fully controlled environment for cell and tissue processing. 

 

Contact us

Dr Gordon McPhee | Facility Manager
Cell Therapy and Regenerative Medicine Platform
Hudson Institute of Medical Research | Translational Research Facility
t: +61 3 8572 2802
e: gordon.mcphee@hudson.org.au

Dr Mirja Krause | Senior Quality Manager
Cell Therapy and Regenerative Medicine Platform
Hudson Institute of Medical Research | Translational Research Facility
t: +61 3 8572 2770
e: mirja.krause@hudson.org.au